Leaky ryanodine receptors in β-sarcoglycan deficient mice: a potential common defect in muscular dystrophy
详细信息 查看全文
- 作者：Daniel C Andersson (1) (4)
Albano C Meli (1) (2)
Steven Reiken (1)
Matthew J Betzenhauser (1)
Alisa Umanskaya (1)
Takayuki Shiomi (3)
Jeanine D’Armiento (3)
Andrew R Marks (1) (3) (5) - 关键词：Muscular dystrophy ; Ryanodine receptor ; Calstabin1 ; Calcium
- 刊名：Skeletal Muscle
- 出版年：2012
- 出版时间：December 2012
- 年：2012
- 卷：2
- 期：1
- 全文大小：875KB
- 参考文献：1. Lim LE, Campbell KP: The sarcoglycan complex in limb-girdle muscular dystrophy. / Curr Opin Neurol 1998, 11:443-52. CrossRef
2. Petrof BJ, Shrager JB, Stedman HH, Kelly AM, Sweeney HL: Dystrophin protects the sarcolemma from stresses developed during muscle contraction. / Proc Natl Acad Sci U S A 1993, 90:3710-714. CrossRef
3. Durbeej M, Cohn RD, Hrstka RF, Moore SA, Allamand V, Davidson BL, Williamson RA, Campbell KP: Disruption of the beta-sarcoglycan gene reveals pathogenetic complexity of limb-girdle muscular dystrophy type 2E. / Mol Cell 2000, 5:141-51. CrossRef
4. Durbeej M, Campbell KP: Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models. / Curr Opin Genet Dev 2002, 12:349-61. CrossRef
5. Lim LE, Duclos F, Broux O, Bourg N, Sunada Y, Allamand V, Meyer J, Richard I, Moomaw C, Slaughter C, Tome FMS, Fardeau M, Jackson CE, Beckmann JS, Campbell KP: Beta-sarcoglycan: characterization and role in limb-girdle muscular dystrophy linked to 4q12. / Nat Genet 1995, 11:257-65. CrossRef
6. Araishi K, Sasaoka T, Imamura M, Noguchi S, Hama H, Wakabayashi E, Yoshida M, Hori T, Ozawa E: Loss of the sarcoglycan complex and sarcospan leads to muscular dystrophy in beta-sarcoglycan-deficient mice. / Hum Mol Genet 1999, 8:1589-598. CrossRef
7. Heydemann A, McNally EM: Consequences of disrupting the dystrophin-sarcoglycan complex in cardiac and skeletal myopathy. / Trends Cardiovasc Med 2007, 17:55-9. CrossRef
8. Gissel H: The role of Ca 2+ in muscle cell damage. / Ann N Y Acad Sci 2005, 1066:166-80. CrossRef
9. Millay DP, Sargent MA, Osinska H, Baines CP, Barton ER, Vuagniaux G, Sweeney HL, Robbins J, Molkentin JD: Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy. / Nat Med 2008, 14:442-47. CrossRef
10. Brookes PS, Yoon Y, Robotham JL, Anders MW, Sheu SS: Calcium, ATP, and ROS: a mitochondrial love-hate triangle. / Am J Physiol Cell Physiol 2004, 287:C817-C833. CrossRef
11. Fong PY, Turner PR, Denetclaw WF, Steinhardt RA: Increased activity of calcium leak channels in myotubes of Duchenne human and mdx mouse origin. / Science 1990, 250:673-76. CrossRef
12. Bradley WG, Fulthorpe JJ: Studies of sarcolemmal integrity in myopathic muscle. / Neurology 1978, 28:670-77. CrossRef
13. Franco A Jr, Lansman JB: Calcium entry through stretch-inactivated ion channels in mdx myotubes. / Nature 1990, 344:670-73. CrossRef
14. Millay DP, Goonasekera SA, Sargent MA, Maillet M, Aronow BJ, Molkentin JD: Calcium influx is sufficient to induce muscular dystrophy through a TRPC-dependent mechanism. / Proc Natl Acad Sci U S A 2009, 106:19023-9028. CrossRef
15. Woods CE, Novo D, DiFranco M, Capote J, Vergara JL: Propagation in the transverse tubular system and voltage dependence of calcium release in normal and mdx mouse muscle fibres. / J Physiol 2005, 568:867-80. CrossRef
16. Woods CE, Novo D, DiFranco M, Vergara JL: The action potential-evoked sarcoplasmic reticulum calcium release is impaired in mdx mouse muscle fibres. / J Physiol 2004, 557:59-5. CrossRef
17. DiFranco M, Woods CE, Capote J, Vergara JL: Dystrophic skeletal muscle fibers display alterations at the level of calcium microdomains. / Proc Natl Acad Sci U S A 2008, 105:14698-4703. CrossRef
18. Andersson DC, Marks AR: Fixing ryanodine receptor Ca leak - a novel therapeutic strategy for contractile failure in heart and skeletal muscle. / Drug Discov Today Dis Mech 2010, 7:e151-e157. CrossRef
19. Brillantes AB, Ondrias K, Scott A, Kobrinsky E, Ondriasova E, Moschella MC, Jayaraman T, Landers M, Ehrlich BE, Marks AR: Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding protein. / Cell 1994, 77:513-23. CrossRef
20. Sun J, Xu L, Eu JP, Stamler JS, Meissner G: Nitric oxide, NOC-12, and S-nitrosoglutathione modulate the skeletal muscle calcium release channel/ryanodine receptor by different mechanisms. An allosteric function for O2 in S-nitrosylation of the channel. / J Biol Chem 2003, 278:8184-189. CrossRef
21. Wehrens XH, Lehnart SE, Huang F, Vest JA, Reiken SR, Mohler PJ, Sun J, Guatimosim S, Song LS, Rosemblit N, D’Armiento JM, Napolitano C, Memmi M, Priori SG, Lederer WJ, Marks AR: FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. / Cell 2003, 113:829-40. CrossRef
22. Andersson DC, Betzenhauser MJ, Reiken S, Meli AC, Umanskaya A, Xie W, Shiomi T, Zalk R, Lacampagne A, Marks AR: Ryanodine receptor oxidation causes intracellular calcium leak and muscle weakness in aging. / Cell Metab 2011, 14:196-07. CrossRef
23. Bellinger AM, Reiken S, Carlson C, Mongillo M, Liu X, Rothman L, Matecki S, Lacampagne A, Marks AR: Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle. / Nat Med 2009, 15:325-30. CrossRef
24. Crosbie RH, Barresi R, Campbell KP: Loss of sarcolemma nNOS in sarcoglycan-deficient muscle. / FASEB J 2002, 16:1786-791. CrossRef
25. Bellinger AM, Reiken S, Dura M, Murphy PW, Deng SX, Landry DW, Nieman D, Lehnart SE, Samaru M, LaCampagne A, Marks AR: Remodeling of ryanodine receptor complex causes "leaky" channels: a molecular mechanism for decreased exercise capacity. / Proc Natl Acad Sci U S A 2008, 105:2198-202. CrossRef
26. Lehnart SE, Mongillo M, Bellinger A, Lindegger N, Chen BX, Hsueh W, Reiken S, Wronska A, Drew LJ, Ward CW, Lederer WJ, Kass RS, Morley G, Marks AR: Leaky Ca2+ release channel/ryanodine receptor 2 causes seizures and sudden cardiac death in mice. / J Clin Invest 2008, 118:2230-245.
27. Wehrens XH, Lehnart SE, Reiken SR, Deng SX, Vest JA, Cervantes D, Coromilas J, Landry DW, Marks AR: Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2. / Science 2004, 304:292-96. CrossRef
28. Yamada T, Place N, Kosterina N, Ostberg T, Zhang SJ, Grundtman C, Erlandsson-Harris H, Lundberg IE, Glenmark B, Bruton JD, Westerblad H: Impaired myofibrillar function in the soleus muscle of mice with collagen-induced arthritis. / Arthritis Rheum 2009, 60:3280-289. CrossRef
29. Colquhoun D, Sigworth FJ: Fitting and statistical analysis of single-channel recording. In / Single-channel recording. Edited by: Sakmann B, Neher E. New York: Plenum; 1983.
30. Aydin J, Andersson DC, Hanninen SL, Wredenberg A, Tavi P, Park CB, Larsson NG, Bruton JD, Westerblad H: Increased mitochondrial Ca 2+ and decreased sarcoplasmic reticulum Ca 2+ in mitochondrial myopathy. / Hum Mol Genet 2009, 18:278-88. CrossRef
31. Jakubiec-Puka A, Biral D, Krawczyk K, Betto R: Ultrastructure of diaphragm from dystrophic alpha-sarcoglycan-null mice. / Acta Biochim Pol 2005, 52:453-60.
32. Allikian MJ, Hack AA, Mewborn S, Mayer U, McNally EM: Genetic compensation for sarcoglycan loss by integrin alpha7beta1 in muscle. / J Cell Sci 2004, 117:3821-830. CrossRef
33. Goonasekera SA, Lam CK, Millay DP, Sargent MA, Hajjar RJ, Kranias EG, Molkentin JD: Mitigation of muscular dystrophy in mice by SERCA overexpression in skeletal muscle. / J Clin Invest 2011, 121:1044-052. CrossRef
34. Angelin A, Tiepolo T, Sabatelli P, Grumati P, Bergamin N, Golfieri C, Mattioli E, Gualandi F, Ferlini A, Merlini L, Maraldi NM, Bonaldo P, Bernardi P: Mitochondrial dysfunction in the pathogenesis of Ullrich congenital muscular dystrophy and prospective therapy with cyclosporins. / Proc Natl Acad Sci U S A 2007, 104:991-96. CrossRef
35. Sasaoka T, Imamura M, Araishi K, Noguchi S, Mizuno Y, Takagoshi N, Hama H, Wakabayashi-Takai E, Yoshimoto-Matsuda Y, Nonaka I, Kaneko K, Yoshida M, Ozawa E: Pathological analysis of muscle hypertrophy and degeneration in muscular dystrophy in gamma-sarcoglycan-deficient mice. / Neuromuscul Disord 2003, 13:193-06. CrossRef
36. Ward CW, Reiken S, Marks AR, Marty I, Vassort G, Lacampagne A: Defects in ryanodine receptor calcium release in skeletal muscle from post-myocardial infarct rats. / FASEB J 2003, 17:1517-519.
37. Allen DG, Lamb GD, Westerblad H: Skeletal muscle fatigue: cellular mechanisms. / Physiol Rev 2008, 88:287-32. CrossRef
38. Wang X, Weisleder N, Collet C, Zhou J, Chu Y, Hirata Y, Zhao X, Pan Z, Brotto M, Cheng H, Ma J: Uncontrolled calcium sparks act as a dystrophic signal for mammalian skeletal muscle. / Nat Cell Biol 2005, 7:525-30. CrossRef
39. Goll DE, Thompson VF, Li H, Wei W, Cong J: The calpain system. / Physiol Rev 2003, 83:731-01.
40. Cohn RD, Durbeej M, Moore SA, Coral-Vazquez R, Prouty S, Campbell KP: Prevention of cardiomyopathy in mouse models lacking the smooth muscle sarcoglycan-sarcospan complex. / J Clin Invest 2001, 107:R1-R7. CrossRef
41. Fauconnier J, Thireau J, Reiken S, Cassan C, Richard S, Matecki S, Marks AR, Lacampagne A: Leaky RyR2 trigger ventricular arrhythmias in Duchenne muscular dystrophy. / Proc Natl Acad Sci U S A 2010, 107:1559-564. CrossRef
42. Shan J, Betzenhauser MJ, Kushnir A, Reiken S, Meli AC, Wronska A, Dura M, Chen BX, Marks AR: Role of chronic ryanodine receptor phosphorylation in heart failure and beta-adrenergic receptor blockade in mice. / J Clin Invest 2010, 120:4375-387. CrossRef - 作者单位：Daniel C Andersson (1) (4)
Albano C Meli (1) (2)
Steven Reiken (1)
Matthew J Betzenhauser (1)
Alisa Umanskaya (1)
Takayuki Shiomi (3)
Jeanine D’Armiento (3)
Andrew R Marks (1) (3) (5)
1. Department of Physiology and Cellular Biophysics, Columbia University College of Physicians and Surgeons, New York, NY, 10032, USA
4. Department of Medicine, Karolinska Institutet, Stockholm, Sweden
2. Faculty of Medicine, Masaryk University, Brno, Czech Republic
3. Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY, 10032, USA
5. Clyde and Helen Wu Center for Molecular Cardiology, New York, NY, 10032, USA - ISSN：2044-5040
文摘
Background Disruption of the sarcolemma-associated dystrophin-glycoprotein complex underlies multiple forms of muscular dystrophy, including Duchenne muscular dystrophy and sarcoglycanopathies. A hallmark of these disorders is muscle weakness. In a murine model of Duchenne muscular dystrophy, mdx mice, cysteine-nitrosylation of the calcium release channel/ryanodine receptor type 1 (RyR1) on the skeletal muscle sarcoplasmic reticulum causes depletion of the stabilizing subunit calstabin1 (FKBP12) from the RyR1 macromolecular complex. This results in a sarcoplasmic reticular calcium leak via defective RyR1 channels. This pathological intracellular calcium leak contributes to reduced calcium release and decreased muscle force production. It is unknown whether RyR1 dysfunction occurs also in other muscular dystrophies. Methods To test this we used a murine model of Limb-Girdle muscular dystrophy, deficient in β-sarcoglycan (Sgcb??. Results Skeletal muscle RyR1 from Sgcb??deficient mice were oxidized, nitrosylated, and depleted of the stabilizing subunit calstabin1, which was associated with increased open probability of the RyR1 channels. Sgcb??deficient mice exhibited decreased muscle specific force and calcium transients, and displayed reduced exercise capacity. Treating Sgcb??mice with the RyR stabilizing compound S107 improved muscle specific force, calcium transients, and exercise capacity. We have previously reported similar findings in mdx mice, a murine model of Duchenne muscular dystrophy. Conclusions Our data suggest that leaky RyR1 channels may underlie multiple forms of muscular dystrophy linked to mutations in genes encoding components of the dystrophin-glycoprotein complex. A common underlying abnormality in calcium handling indicates that pharmacological targeting of dysfunctional RyR1 could be a novel therapeutic approach to improve muscle function in Limb-Girdle and Duchenne muscular dystrophies.